SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hannah Joseph Hospital Ltd (544687)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544687 NSE: Hospital & Healthcare Services | Small Cap | Hannah Joseph Hospit Share Price

₹124 1.30 (1.06%)

As on 06-Jul'26 16:59

Hannah Joseph Hospital Ltd (544687)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544687 NSE: Hospital & Healthcare Services | Small Cap | Hannah Joseph Hospit Share Price

₹124 1.30 (1.06%)

As on 06-Jul'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹281 Cr.
Current Price
₹124
52-Week Low / High
₹56 / 124
TTM EPS
₹4.9
TTM Sales
₹92.1 Cr.
Book Value per Share
₹41.8
P/E Ratio
25.17
Higher than its 5-year historical median
Industry PE
93.9
Price to Book (P/B)
2.97
Higher than its 5-year historical median
Price to Sales (P/S)
3.06
Higher than its 5-year historical median
EV/EBITDA
10.25
Higher than its 5-year historical median
Dividend Yield
1.61%
Profitability Efficiency
Return on Equity (ROE)
15.55%
Outperforms industry median
Return on Capital Employed (ROCE)
18.72%
Outperforms industry median
Return on Assets (ROA)
9.74%
Operating Profit Margin
27.4%
Net Profit Margin
12.15%
Gross Profit Margin
24.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
18.73%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
21.8%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
55.06%
Asset Quality
Promoter Holding
71.28%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹75 Cr.
Equity
₹22.7 Cr.
Face Value
₹10
All Time Low / High
₹55.99 / 122.70

Hannah Joseph Hospital stock performance

Key Ratios
mw4me loader

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Hannah Joseph Hospital Ltd a good quality company?
Hannah Joseph Hospital Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Hannah Joseph Hospital Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Hannah Joseph Hospital Ltd vs industry peers?
Hannah Joseph Hospital Ltd revenue CAGR is 10.09%, compared to the industry median CAGR of 6.53%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Hannah Joseph Hospital Ltd?
Promoters hold 71.28% of the Hannah Joseph Hospital Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Hannah Joseph Hospital Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Hannah Joseph Hospital Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % 10.8%10%13.3%17.5%18.7%-
Value Creation
Index
-0.2-0.3-0.10.30.3-

Growth Parameters

Sales 58.154.663.477.592.192
Sales YoY Gr.--6%16.1%22.3%18.7%-
Adj EPS 0.20.62.44.34.94.9
YoY Gr.-200%287.3%77.1%13.9%-
BVPS (₹) 15.620.926.329.341.841.8
Adj Net
Profit
0.314.17.211.211
Cash Flow from Ops. 15.720.8819.420.7-
Debt/CF from Ops. 32.13.91.71.2-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANA19%18.7%
Adj EPS NANA98.4%13.9%
BVPSNANA26%42.7%
Share Price - - - -

Key Financial Parameters

Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity %
1.43.510.114.81511.8
Op. Profit
Mgn %
31.930.328.626.727.4NAN
Net Profit
Mgn %
0.61.96.49.312.112.2
Debt to
Equity
1.91.30.70.70.3-
Working Cap
Days
0607361430
Cash Conv.
Cycle
05202170

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25Mar'26
Sales5855637892
Operating Expenses + 4038455767
Manufacturing Costs7782428
Material Costs9791214
Employee Cost 11910910
Other Costs 1415181216
Operating Profit 1917182125
Operating Profit Margin (%) 31.9%30.2%28.6%26.7%27.4%
Other Income + 00001
Exceptional Items 00000
Interest 76533
Depreciation 119877
Profit Before Tax 1151016
Tax 00135
Profit After Tax 014711
PAT Margin (%) 0.6%1.9%6.4%9.3%12.2%
Adjusted EPS (₹)0.20.62.44.34.9
Dividend Payout Ratio (%)0%0%0%0%40.60%

Valuation of Hannah Joseph Hospit - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 2535465297
Share Capital 1116171723
Reserves 1418293575
Debt +4335263223
Long Term Debt4130262823
Short Term Debt35040
Minority Interest00000
Trade Payables33334
Others Liabilities 131815108
Total Liabilities 84908997133

Fixed Assets

Net Fixed Assets +7771656973
Gross Block100104106117128
Accumulated Depreciation2433414855
CWIP 00015
Investments 00000
Inventories11112
Trade Receivables26854
Cash Equivalents flag 1791243
Others Assets 35686
Total Assets 84908997133

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity + 162181921
PBT 1151016
Adjustment 1816131110
Changes in Working Capital -34-101-0
Tax Paid 000-3-5
Cash Flow From Investing Activity + -3-5-4-14-14
Capex -2-4-2-11-10
Net Investments 00000
Others -1-1-1-2-4
Cash Flow From Financing Activity + -13-10-3-325
Net Proceeds from Shares 097035
Net Proceeds from Borrowing -5-11-30-8
Interest Paid -7-6-5-3-3
Dividend Paid 00000
Others -1-2-200
Net Cash Flow 152332

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)1.373.4310.4215.5315.55
ROCE (%)10.771013.3117.5118.72
Asset Turnover Ratio0.690.630.710.830.8
PAT to CFO Conversion(x)N/A2122.711.91
Working Capital Days
Receivable Days13.5025.7038.9031.3018.70
Inventory Days5.6088.306.706.80
Payable Days106.70129.80105.7085.9085.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Hannah Joseph Hospital Ltd FAQs

The current trading price of Hannah Joseph Hospit on 06-Jul-2026 16:59 is ₹124.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 05-Jul-2026 the market cap of Hannah Joseph Hospit stood at ₹281.5 Cr

The latest P/E ratio of Hannah Joseph Hospit as of 05-Jul-2026 is 25.17.

The latest P/B ratio of Hannah Joseph Hospit as of 05-Jul-2026 is 2.97.

The 52-week high of Hannah Joseph Hospit is ₹124.0 and the 52-week low is ₹55.99.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hannah Joseph Hospit is ₹92.05 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Hannah Joseph Hospital Ltd is a average quality company.

The key valuation ratios of Hannah Joseph Hospital Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Hannah Joseph Hospital Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Hannah Joseph Hospital Ltd

Hannah Joseph Hospital was incorporated as ‘Hannah Joseph Hospital Private Limited’ at Tamil Nadu as a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated October 24, 2011, issued by the Registrar of Companies (ROC), Tamil Nadu, Chennai, Andaman and Nicobar Islands. Subsequently, the company was converted to a public limited company and the name of the company changed to ‘Hannah Joseph Hospital Limited’ on July 29, 2022.

The company is a multi-speciality healthcare provider, strategically located in Madurai, operating in a two acres campus, centrally air-conditioned hospital with central water heating system. It is a growing organization that aims at strengthening and establishing its presence in healthcare services providers. It strives to serve with its ultra-modern medical practices and state of the art infrastructure for medical as well as surgical care solutions. It has been consistently registering phenomenal growth in terms of complicated surgeries, patient volume and turnover making the hospital a landmark for neurosciences in the city of Madurai & South Tamil Nadu. Its medical facility encompasses full-fledged department of neuroradiology by meeting standards of Neurological Institute of International Standard. The company has also added the department of cardiac sciences with a Cath lab and cardiac operation theatres. The company also performs complex coronary angioplasties and open-heart Surgeries.

It was assessed and found to comply with NABH Accreditation Standards for Hospital 5th edition and has been awarded with a Certificate of Accreditation from National Accreditation Board for Hospitals and Healthcare Provider. Further, it has also received NABL 128 Certification from National Accreditation Board for Testing and Calibration Laboratories.  Its primary focus is Neurology, Cardiology, Psychiatry and Trauma healthcare where it has an understanding of global nuances, customer culture and the mindset of medical professionals and where there is a significant need for quality and affordable healthcare services.

Business area of the company

The company is renowned for its comprehensive and specialized medical care in Neurosciences, Cardiac Sciences, Orthopaedics, and Traumatology. Catering predominantly to the population of Central and South Tamil Nadu, the hospital stands out for its advanced medical services, commitment to patient care, and cutting-edge technologies. 

Services of the company

  • Neurosurgery
  • Neurology
  • Cardiology
  • Orthopaedics
  • Oral & Maxillofacial Surgery
  • Psychiatry
  • Radiology Services
  • Intensive Care Unit (ICU)
  • Intensive Cardiac Care Unit (ICCU)
  • Pathology Services

Awards and recognitions of the company

  • 2021: Excellence in Quality Awards to the Best Entry Level NABH Certified Neurology Specialty Hospital from the Tamil Nadu Government and FICCI.
  • 2023: Excellence in Neuroscience and Trauma Care award presented by the Times Business Awards
  • 2023: Ranked 1st in the Madurai city and among top 20 for Neuroscience in the South India comprising of 5 states and 2 union territories, as per the National Survey conducted by the Times of India
  • 2024: Neurosurgery Excellence Award for expertise in Innovation & Complex Neurosurgical Procedures from News18
  • 2025: Times Award 2025 (Madurai & Trichy regions) for Excellence in Neurosurgery & Interventional Neuroradiology in 2025.
  • 2025: Ranked No. 2 in India in the Best Neurosurgery Hospitals category by Outlook in association with NEB Research, published on June 2025.
  • 2025: Healthcare Excellence Award in Neurology (Above 100 Beds) Conferred on October 11, 2025 by the Confederation of Indian Industry (CII), Tamil Nadu during the MedClave 2025 event.
  • 2025: AHPI-TN Excellence Awards 2025, awarded by the AHPI Tamil Nadu Chapter on November 08, 2025.

History and milestones

  • 2011: Incorporation of the company as Hannah Joseph Hospital Private Limited
  • 2015: Intra Operative Neuro Monitoring was introduced
  • 2016: A complex high-risk surgery was performed with global fusion done at the brain spine junction on a young boy in 2 phases
  • 2017: Brain Lab Navigation was introduced
  • 2018: A brain tumour was removed using local anaesthesia and brain mapping with the patient fully conscious
  • 2020: The Hospital was shifted to its new campus which is spread over an area of 2 Acres with 150 Beds
  • 2021: The Neuro-endovascular Intervention for a Brain Aneurysm using ‘Silk Vista’ was performed
  • 2022: Conversion of Private Limited to Public Limited - Hannah Joseph Hospital Limited
  • 2022: Successfully performed the Sapien 3 Trans Catheter Heart Valve Implantation using Edwards Delivery System
  • 2022: A rare and complex Giant tumour was successfully removed from the CV junction (Brain/Spine junction) in a paediatric patient
  • 2022: The Interventional Neuroradiology team launched the advanced Intrasaccular Web Device (ISD) for the Endovascular treatment of Aneurysm patient
  • 2023: Hannah Joseph hospital has been Fully Accredited in NABH National Accreditation Board for Hospitals & Healthcare Providers (5th Edition) and NABL (National Accreditation Board for Hospitals & Healthcare Providers)
  • 2023: The Institute started six years Direct Dr NB Neurosurgery courses for post MBBS graduates offering 2 seats every year. 
  • 2023: A rare case of the Temporomandibular Joint Replacement Surgery was done by the Department of Oral Maxillofacial Surgery
  • 2024: Brain lab Fiber tracking Navigation 3.0 version for removing brain tumours has been launched
  • 2025: Performed a life- saving neuroendovascular procedure on a nine month old baby boy, diagnosed with a complex brain aneurysmal rupture, using ballon- assisted coils in the brain
  • 2025: Acquired land for Construction of Radiation Oncology Centre

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: